FDA Approves New Type 2 Diabetes Treatment

September 25, 2019

The FDA has approved Rybelsus to control blood sugar in adults with type 2 diabetes. The drug is the first oral glucagon-like peptide receptor protein treatment to be approved in the United States.

Lisa Yanoff, acting director of the Division of Metabolism and Endocrinology Products at the FDA, said, “Patients want effective treatment options for diabetes that are as minimally intrusive on their lives as possible, and the FDA welcomes the advancement of new therapeutic options that can make it easier for patients to control their condition.” 

Read the FDA press release here.